Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Telcare gets $25.4mm in first close of Series B

Executive Summary

Glucose monitoring device developer Telcare Inc. has raised $25.4mm in the first close of its Series B financing led by new investor Sequoia Capital with participation from returning shareholder Qualcomm (through its Qualcomm Life Fund) and undisclosed investors. According to the Form D, the company could bring in another $13.1mm in the round.

Deal Industry
  • Medical Devices
  • Medical Devices
    • Diagnostic Equipment & Supplies
  • In Vitro Diagnostics
    • Glucose Testing
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies